Johannesburg - The South African Health Products Regulatory Authority (SAHPRA) participated in the fourth edition of 2023 The Pharmacy Show (TPS) during 15-16 March 2023, at the Sandton Convention Centre. The Pharmacy Show is the leading networking and business event for everyone involved in supplying, marketing,...
KwaZulu-Natal - The South African Health Products Regulatory Authority (SAHPRA) has participated in the 36th Annual South African Association of Hospital and Institutional Pharmacists (SAAHIP) Annual Conference during 09 -11 March 2023, in KwaZulu-Natal. SAHPRA also had an opportunity to exhibit where information was shared...
1 March 2023 The COVID-19 pandemic turned the spotlight on the South African Health Products Regulator (SAHPRA), with many people expecting the regulator to approve medication that would see the end to the virus, but more often with limited understanding of the processes involved in reaching...
Pretoria, 23 February 2023 - The South African Health Products Regulatory Authority (SAHPRA) hosted the Regional Quality Management Systems (QMS) Technical Working Group Workshop during 20 - 23 February 2023 at Protea Hotel – OR Tambo Airport. The participating countries included: Angola, Botswana, Eswatini, Lesotho,...
Pretoria, 30 January 2023 – The South African Health Products Regulatory Authority (SAHPRA) has registered Paxlovid, an anti-viral medicine manufactured by Pfizer, to treat COVID-19. Paxlovid, which contains Nirmatrelvir (150mg) and Ritonavir (100mg), is a medicine that is used for the treatment of mild to moderate...
The US Agency for International Development (USAID), the American National Standards Institute (ANSI), and Advanced Medical Technology Association (AdvaMed) is hosting a Workshop on Good Regulatory Practices and its implementation in the Medical Device Sector on 31 January and 01 February 2023. To register, click here. Read...
Many of you have heard about this strange sounding medication, Cabotegravir (Cah-bot-er-grah-ver), floating around news broadcasts and print outlets. Well, this medication is a Human Immunodeficiency Virus (HIV) anti-retroviral (ARV) that has been recently approved by the South African Health Products Regulatory Authority (SAHPRA). What is...
Pretoria, 2 December 2022 – The South African Health Products Regulatory Authority (SAHPRA) has registered Cabotegravir (Apretude 600 mg/3ml injection), a long-acting HIV pre-exposure prophylactic. Cabotegravir is an antiretroviral drug (ARV) that people living with HIV may use, together with other ARVs, to keep the virus...
Pretoria, 2 December 2022 – With the establishment of the South African Health Products Regulatory Authority (SAHPRA) in February 2018, the regulatory authority inherited a backlog of approximately 16 000 new product and variation applications from its predecessor, the Medicines Control Council (MCC). As is generally...
Pretoria, 24 November 2022 – In the past year, the South African Health Products Regulatory Authority (SAHPRA) approved the antigen test kits for use by healthcare professionals. SAHPRA has now approved seven (7) COVID-19 antigen self-test kits that can be used as self-test/ at home tests...
